-
Full Article (HTML) (42) -
Full Article (PDF) (4)
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1427)
All Articles published online
|
Jul 7, 2009 (publication date) through Aug 7, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Chenggang Shi, Jiyi Huang, Xun Liu, Xiaolin Zeng, Cailian Cheng, Qiongli Yin, Mei Li, Guifeng Cheng. Diagnostic significance of hepatitis B viral antigens in patients with glomerulonephritis-associated hepatitis B virus infection. Diagnostic Microbiology and Infectious Disease 2012; 72(2): 156 doi: 10.1016/j.diagmicrobio.2011.11.003
|
| 2 |
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical Gastroenterology and Hepatology 2015; 13(12): 2071 doi: 10.1016/j.cgh.2015.07.007
|
| 3 |
Özge Gümüşay, Seren Özenirler, Ayşegül Atak, Cemile Sönmez, Seçil Özkan, Ayşe Fıtnat Tuncel, Güldal Yılmaz, Gülen Akyol. Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. Hepatology Research 2013; 43(3): 228 doi: 10.1111/j.1872-034X.2012.01057.x
|
| 4 |
Simon Peter Kayondo, Josaphat K Byamugisha, Peter Ntuyo. Prevalence of hepatitis B virus infection and associated risk factors among pregnant women attending antenatal clinic in Mulago Hospital, Uganda: a cross-sectional study. BMJ Open 2020; 10(6): e033043 doi: 10.1136/bmjopen-2019-033043
|
| 5 |
Danielle Alves Gomes Zauli, Carla Lisandre Paula de Menezes, Cristiane Lommez de Oliveira, Elvis Cristian Cueva Mateo, Alessandro Clayton de Souza Ferreira. In-house quantitative real-time PCR for the diagnosis of hepatitis B virus and hepatitis C virus infections. Brazilian Journal of Microbiology 2016; 47(4): 987 doi: 10.1016/j.bjm.2016.07.008
|
| 6 |
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis B. World Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
|
| 7 |
Jingui Bao, Yu Lu, Yan Deng, Chengzhi Rong, Yanqiong Liu, Xiuli Huang, Liuying Song, Shan Li, Xue Qin. Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control study. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0223-z
|
| 8 |
Georgia Zeng, Upkar S Gill, Patrick T F Kennedy. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis. Gut 2020; : gutjnl-2020-321627 doi: 10.1136/gutjnl-2020-321627
|
| 9 |
Ying-Hui Shi. Correlation between Hepatitis B Virus Genotypes and Clinical Outcomes. Japanese Journal of Infectious Diseases 2012; 65(6): 476 doi: 10.7883/yoken.65.476
|
| 10 |
Young Min Park. Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome. World Journal of Hepatology 2015; 7(1): 113-120 doi: 10.4254/wjh.v7.i1.113
|
| 11 |
Ersan Ozaslan, Tugrul Purnak. Controversies about occult hepatitis B virus infection. World Journal of Gastroenterology 2009; 15(39): 4986-4987 doi: 10.3748/wjg.15.4986
|
| 12 |
Luisa Barboza, Siham Salmen, Guillermo Teran-Angel, Darrell L. Peterson, Lisbeth Berrueta. A deficient translocation of CD3ζ, ZAP-70 and Grb2 to lipid raft, as a hallmark of defective adaptive immune response during chronic hepatitis B infection. Cellular Immunology 2013; 284(1-2): 9 doi: 10.1016/j.cellimm.2013.05.008
|
| 13 |
Anusha Vittal, Marc G. Ghany. WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBV. Clinics in Liver Disease 2019; 23(3): 417 doi: 10.1016/j.cld.2019.04.008
|
| 14 |
Xiaolei Jiao, Ying Luo, Bin Yang, Li Jing, Yayue Li, Changzheng Liu, Xiang Jing, Fengmei Wang, Yijun Wang, Zhi Du, Yingtang Gao. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker. Infection, Genetics and Evolution 2017; 49: 66 doi: 10.1016/j.meegid.2017.01.008
|
| 15 |
Marta Bes, Victor Vargas, Maria Piron, Natalia Casamitjana, Juan Ignacio Esteban, Nuria Vilanova, Asuncion Pinacho, Josep Quer, Lluis Puig, Jaime Guardia, Silvia Sauleda. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. Journal of Hepatology 2012; 56(4): 765 doi: 10.1016/j.jhep.2011.11.011
|
| 16 |
R.K. Mondal, M. Khatun, S. Ghosh, P. Banerjee, S. Datta, S. Sarkar, B. Saha, A. Santra, S. Banerjee, A. Chowdhury, S. Datta. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from human immunodeficiency virus/hepatitis B virus coinfection. Clinical Microbiology and Infection 2015; 21(7): 710.e11 doi: 10.1016/j.cmi.2015.03.004
|
| 17 |
Onur Gokce, Seren Ozenirler, Aysegul Atak Yucel, Nihan Oruklu, Guldal Yilmaz Esendagli, Sevilay Karahan. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2018; 30(8): 918 doi: 10.1097/MEG.0000000000001123
|
| 18 |
Young Min Park, Seong Gyu Lee. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study. World Journal of Gastroenterology 2016; 22(44): 9836-9843 doi: 10.3748/wjg.v22.i44.9836
|
| 19 |
|
| 20 |
Hui Nie, Alison A. Evans, W. Thomas London, Timothy M. Block, Xiangdong David Ren. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion. Journal of Hepatology 2012; 56(4): 795 doi: 10.1016/j.jhep.2011.11.012
|
| 21 |
Louise Rodrigues, Natalia Freitas, Bhaskar V. Kallakury, Stephan Menne, Severin O. Gudima, G. McFadden. Superinfection with Woodchuck Hepatitis Virus Strain WHVNY of Livers Chronically Infected with Strain WHV7. Journal of Virology 2015; 89(1): 384 doi: 10.1128/JVI.02361-14
|
| 22 |
Sohair K. Sayed, Mohammad A. kobeisy. The relationship between core promoter mutation of hepatitis B virus, viral load and hepatitis B e antigen status in chronic hepatitis B patients. Cellular Immunology 2012; 276(1-2): 35 doi: 10.1016/j.cellimm.2012.03.003
|
| 23 |
Koffi Alain Attia, Ya Henriette Kissi, Stanislas Doffou, Demba Bangoura, Roseline Flora Wilson, Georges Bougha, Fulgence Yao Bathaix, Kouame Alassan Mahassadi, Mohamed Sayegh, Therese N’dri-Yoman. Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier subjects. Open Journal of Gastroenterology 2013; 3(04): 237 doi: 10.4236/ojgas.2013.34040
|
| 24 |
C. Gauder, L.N. Mojsiejczuk, L. Tadey, L. Mammana, M.B. Bouzas, R.H. Campos, D.M. Flichman. Role of viral load in Hepatitis B virus evolution in persistently normal ALT chronically infected patients. Infection, Genetics and Evolution 2019; 67: 17 doi: 10.1016/j.meegid.2018.10.017
|
| 25 |
Bernd Koeberlein, Axel zur Hausen, Nuran Bektas, Hanswalter Zentgraf, Ruth Chin, Nguyen Linh Toan, Reinhard Kandolf, Joseph Torresi, C.- Thomas Bock. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Research 2010; 148(1-2): 51 doi: 10.1016/j.virusres.2009.12.003
|
| 26 |
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Ya-Ting Gao, Yun Jiang, Yue-Qiu Gao. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence. Laboratory Investigation 2016; 96(11): 1156 doi: 10.1038/labinvest.2016.96
|
| 27 |
Tianju Wang, Chunmei Shen, Liping Chen, Sheng Liu, Yanhong Ji. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population. The Journal of Gene Medicine 2017; 19(9-10): e2987 doi: 10.1002/jgm.2987
|
| 28 |
Yong Jin Jung, Jin-Wook Kim, Soo Jin Park, Bo Young Min, Eun Sun Jang, Nam Young Kim, Sook-Hyang Jeong, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Nayoung Kim, Dong Ho Lee. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells. Journal of Medical Virology 2013; 85(6): 969 doi: 10.1002/jmv.23534
|
| 29 |
John R. Brill. Sexually Transmitted Infections in Men. Primary Care: Clinics in Office Practice 2010; 37(3): 509 doi: 10.1016/j.pop.2010.04.003
|
| 30 |
Ban M. Al-Kanaan, Mushtak T.S. Al-Ouqaili, Khalid F.A. Al-Rawi. Detection of cytokines (IL-1α and IL-2) and oxidative stress markers in hepatitis B envelope antigen-positive and -negative chronic hepatitis B patients: Molecular and biochemical study. Gene Reports 2019; 17: 100504 doi: 10.1016/j.genrep.2019.100504
|
| 31 |
György Berencsi, Márta Csire. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis. 2012; : 105 doi: 10.1007/978-94-007-4216-1_4
|
| 32 |
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
|
| 33 |
Yu Lu, Jie Zeng, Shi Yang, Zuojian Hu, Limin Li, Hongli Yu, Xue Qin. Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV-related hepatocellular carcinoma in a Guangxi population. Journal of Clinical Laboratory Analysis 2020; : e23310 doi: 10.1002/jcla.23310
|
| 34 |
Ferruccio Bonino, Maurizia Rossana Brunetto. Occult Hepatitis B Virus (HBV) Infections: Hepatitis B Surface Antigen (HBsAg) Negative and Primary Occult. Current Hepatitis Reports 2013; 12(2): 112 doi: 10.1007/s11901-013-0164-8
|
| 35 |
Dramane Kania, Laure Ottomani, Nicolas Meda, Marianne Peries, Pierre Dujols, Karine Bolloré, Wendy Rénier, Johannes Viljoen, Jacques Ducos, Philippe Van de Perre, Edouard Tuaillon. Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitation. Journal of Virological Methods 2014; 201: 24 doi: 10.1016/j.jviromet.2014.01.015
|
| 36 |
Man Li, Zhen-Hua Zhou, Xue-Hua Sun, Xin Zhang, Xiao-Jun Zhu, Shu-Gen Jin, Yun Jiang, Ya-Ting Gao, Cheng-Zhong Li, Yue-Qiu Gao. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection. Hepatology International 2016; 10(4): 594 doi: 10.1007/s12072-015-9650-0
|
| 37 |
Mona Abdel-Hady, Deirdre Kelly. Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management. Pediatric Drugs 2013; 15(4): 311 doi: 10.1007/s40272-013-0010-z
|
| 38 |
Neil D. Theise, Henry C. Bodenheimer, Linda D. Ferrell. MacSween's Pathology of the Liver. 2012; : 361 doi: 10.1016/B978-0-7020-3398-8.00007-6
|
| 39 |
Man Li, Xue-Hua Sun, Xiao-Jun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhen-Hua Zhou, Zhuo Yu, Yue-Qiu Gao. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Laboratory Investigation 2012; 92(2): 295 doi: 10.1038/labinvest.2011.157
|
| 40 |
Amr Abdelkader Fateen, Rasha Youssef Shahin, Mohamed Nazmy Farres, Mai Ahmed Eldeeb, Hanaa Ahmed Amer. Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt. Annals of Hepatology 2012; 11(4): 464 doi: 10.1016/S1665-2681(19)31459-0
|
| 41 |
Christos Liaskos, Athanasios Mavropoulos, Timoklia Orfanidou, Vassiliki Spyrou, Labrini V. Athanasiou, Charalambos Billinis. The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis. Autoimmunity Highlights 2012; 3(3): 87 doi: 10.1007/s13317-012-0036-1
|
| 42 |
Agnieszka Lawrenczyk, Seil Kim, Xiangshu Wen, Ran Xiong, Weiming Yuan. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment. Pathogens 2014; 3(3): 563 doi: 10.3390/pathogens3030563
|
| 43 |
Chia-Hsuin Chang, Jou-Wei Lin, Yu-Kang Tu. Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan. Journal of Clinical Epidemiology 2015; 68(4): 405 doi: 10.1016/j.jclinepi.2014.11.014
|
| 44 |
Xinying Zhao, Xudong Guo, Libo Xing, Wenqin Yue, Haisen Yin, Miaoxia He, Jianmin Wang, Jianmin Yang, Jie Chen. HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0097-1
|
| 45 |
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
|
| 46 |
Edina Amponsah-Dacosta, Ramokone L. Lebelo, J. Nare Rakgole, Rosemary J. Burnett, Selokela G. Selabe, M. Jeffrey Mphahlele. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. Journal of Medical Virology 2014; 86(6): 918 doi: 10.1002/jmv.23910
|
| 47 |
M. Sui, R. Wu, X. Hu, H. Zhang, J. Jiang, Y. Yang, J. Niu. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. Journal of Viral Hepatitis 2014; 21(12): 925 doi: 10.1111/jvh.12302
|
| 48 |
Neetu Rohit Kapoor, Vijay Kumar. Hepatitis B Virus: A Molecular Perspective. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 2012; 82(1): 31 doi: 10.1007/s40011-011-0003-z
|
| 49 |
Wei Pan, Zuoqiao Wu, Shuwen Wu, Deyin Guo, Xiaoyan Gong, Tien Po. Human Immunodeficiency Virus Coinfection with Hepatitis B Virus Leads to a Decrease in Extracellular and Intracellular Hepatitis B Antigen. AIDS Research and Human Retroviruses 2015; 31(4): 461 doi: 10.1089/aid.2014.0291
|
| 50 |
Matthew B Carroll. The impact of biologic response modifiers on hepatitis B virus infection. Expert Opinion on Biological Therapy 2011; 11(4): 533 doi: 10.1517/14712598.2011.554810
|
| 51 |
DA-WU ZENG, YU-RUI LIU, JING DONG, YUE-YONG ZHU, YOU-BING LI, JING CHEN, QI ZHENG, JIA-JI JIANG. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection. Molecular Medicine Reports 2015; 11(5): 3465 doi: 10.3892/mmr.2015.3207
|
| 52 |
Hai-hua Sun, Dong-fang Zhou, Jun-ying Zhou. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. Journal of Medical Virology 2016; 88(1): 13 doi: 10.1002/jmv.24306
|
| 53 |
M. Estée Török. Manson's Tropical Infectious Diseases. 2014; : 112 doi: 10.1016/B978-0-7020-5101-2.00014-5
|
| 54 |
Stefan Wirth. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2016; : 681 doi: 10.1007/978-3-319-17169-2_60
|
| 55 |
Zhao H. Hou, Qiu J. Han, Cai Zhang, Zhi G. Tian, Jian Zhang. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes. Liver International 2014; 34(1): 58 doi: 10.1111/liv.12244
|